| Name | ethyl 2,3-dihydro-1,4-benzodioxine-6-carboxylate | 
|---|---|
| Synonyms | 2,3-dihydro-benzo[1,4]dioxin-6-carboxylic acid ethyl ester 2,3-Dihydro-benzo[1,4]dioxin-6-carbonsaeure-aethylester ethyl 2,3-dihydrobenzo[b][1,4]dioxine-6-carboxylate 2,3-dihydro-benzo[1,4]dioxine-6-carboxylic acid ethyl ester | 
| Molecular Formula | C11H12O4 | 
|---|---|
| Molecular Weight | 208.21100 | 
| Exact Mass | 208.07400 | 
| PSA | 44.76000 | 
| LogP | 1.63450 | 
| Vapour Pressure | 0.001mmHg at 25°C | 
| HS Code | 2932999099 | 
|---|
| ~28%   20825-87-0 | 
| Literature: Vertex Pharmaceuticals Incorported Patent: US2011/98311 A1, 2011 ; | 
| ~%   20825-87-0 | 
| Literature: Bioorganic and Medicinal Chemistry, , vol. 20, # 4 p. 1373 - 1379 | 
| Precursor 4 | |
|---|---|
| DownStream 2 | |
| HS Code | 2932999099 | 
|---|---|
| Summary | 2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |